BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17482959)

  • 1. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
    Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
    Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
    Wang YH; Chiou HY; Lin CT; Hsieh HY; Wu CC; Hsu CD; Shen CH
    Urology; 2009 Mar; 73(3):670-4. PubMed ID: 19038421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
    Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
    Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Oliver J; Sanchez E; Garcia-Porrua C; Paco L; Lopez-Nevot MA; Ollier WE; Martin J
    J Rheumatol; 2005 Nov; 32(11):2178-82. PubMed ID: 16265698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding.
    Motallebipour M; Rada-Iglesias A; Jansson M; Wadelius C
    Mol Vis; 2005 Nov; 11():950-7. PubMed ID: 16288199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.
    Li C; Hu Z; Liu Z; Wang LE; Gershenwald JE; Lee JE; Prieto VG; Duvic M; Grimm EA; Wei Q
    Cancer; 2007 Apr; 109(8):1570-8. PubMed ID: 17328085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
    Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
    Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking.
    Wang H; Liu Y; Tan W; Zhang Y; Zhao N; Jiang Y; Lin C; Hao B; Zhao D; Qian J; Lu D; Jin L; Wei Q; Lin D; He F
    Cancer Sci; 2008 Apr; 99(4):787-91. PubMed ID: 18294291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival after ischemic stroke in postmenopausal women is affected by an interaction between smoking and genetic variation in nitric oxide synthases.
    Oksala NK; Oksala A; Erkinjuntti T; Pohjasvaara T; Kunnas T; Vataja R; Kaste M; Karhunen PJ
    Cerebrovasc Dis; 2008; 26(3):250-8. PubMed ID: 18648197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases.
    Holla LI; Stejskalova A; Znojil V; Vasku A
    Clin Exp Allergy; 2006 Dec; 36(12):1592-601. PubMed ID: 17177683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand.
    Ohashi J; Naka I; Patarapotikul J; Hananantachai H; Looareesuwan S; Tokunaga K
    J Infect Dis; 2002 Aug; 186(4):578-81. PubMed ID: 12195390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.
    Ryk C; Steineck G; Wiklund NP; Nyberg T; de Verdier PJ
    J Urol; 2010 Nov; 184(5):2150-7. PubMed ID: 20850837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.
    Amasyali AS; Kucukgergin C; Erdem S; Sanli O; Seckin S; Nane I
    J Urol; 2012 Dec; 188(6):2398-403. PubMed ID: 23088972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (CCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy.
    Konno S; Hizawa N; Yamaguchi E; Jinushi E; Nishimura M
    J Allergy Clin Immunol; 2001 Nov; 108(5):810-4. PubMed ID: 11692109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter.
    Tatemichi M; Sawa T; Gilibert I; Tazawa H; Katoh T; Ohshima H
    Cancer Lett; 2005 Jan; 217(2):197-202. PubMed ID: 15617837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of hOGG1 and XPD polymorphisms with urothelial carcinoma in Taiwan.
    Wang YH; Yeh SD; Shen KH; Shen CH; Tung MC; Liu CT; Chiou HY
    Anticancer Res; 2011 Nov; 31(11):3939-44. PubMed ID: 22110223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.